BioCentury
ARTICLE | Company News

Amgen, SkyePharma deal

April 10, 2000 7:00 AM UTC

SKP will use its DepoFoam sustained release injectable system to formulate an undisclosed AMGN product. Under the first phase of the agreement, AMGN will evaluate the DepoFoam technology for use with ...